Subgroup specific therapy effects in AML: AMLCG data.
Büchner
Th
T
German AMLCG, Department of Medicine, Hematology and Oncology, University of Münster, Germany.
Hiddemann
W
W
Berdel
W E
WE
Wörmann
B
B
Schoch
C
C
Fonatsch
C
C
Löffler
H
H
Haferlach
T
T
Ludwig
W D
WD
Maschmeyer
G
G
Staib
P
P
Balleisen
L
L
Grüneisen
A
A
Aul
C
C
Lengfelder
E
E
Hehlmann
R
R
Kern
W
W
Serve
H L
HL
Mesters
R M
RM
Eimermacher
H
H
Frickhofen
N
N
Kienast
J
J
Giagounidis
A
A
Sauerland
M C
MC
Heinecke
A
A
D018572:Disease-Free Survival; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000145:classification / Q000188:drug therapy* / Q000401:mortality; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D016019:Survival Analysis